Joinn Laboratories Returns to Profit in H1; Shares Slide 5%

MT Newswires Live

Aug 27

Joinn Laboratories (HKG:6127, SHA:603127) posted a profit attributable to equity shareholders of 60.9 million yuan for the first half of 2025, reversing a loss of 169.7 million yuan a year earlier, according to a Tuesday Hong Kong bourse filing.

Hong Kong-listed shares of the pharma research company fell nearly 5% in afternoon trade on Wednesday.

Earnings per share came in at 0.08 yuan, compared with a loss per share of 0.23 yuan in the prior-year period.

Revenue fell to 668.6 million yuan from 849.4 million yuan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2562713133"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2562713133\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2562713133?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-27 16:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2562713133","market":"sg","top_or_hot":-1,"title":"Joinn Laboratories Returns to Profit in H1; Shares Slide 5%","media":"MT Newswires Live","content":"<html><body><p> Joinn Laboratories (HKG:6127, SHA:603127) posted a profit attributable to equity shareholders of 60.9 million yuan for the first half of 2025, reversing a loss of 169.7 million yuan a year earlier, according to a Tuesday Hong Kong bourse filing.</p><p>Hong Kong-listed shares of the pharma research company fell nearly 5% in afternoon trade on Wednesday.</p><p>Earnings per share came in at 0.08 yuan, compared with a loss per share of 0.23 yuan in the prior-year period.</p><p>Revenue fell to 668.6 million yuan from 849.4 million yuan.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Joinn Laboratories Returns to Profit in H1; Shares Slide 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJoinn Laboratories Returns to Profit in H1; Shares Slide 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-27 16:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Joinn Laboratories (HKG:6127, SHA:603127) posted a profit attributable to equity shareholders of 60.9 million yuan for the first half of 2025, reversing a loss of 169.7 million yuan a year earlier, according to a Tuesday Hong Kong bourse filing.</p><p>Hong Kong-listed shares of the pharma research company fell nearly 5% in afternoon trade on Wednesday.</p><p>Earnings per share came in at 0.08 yuan, compared with a loss per share of 0.23 yuan in the prior-year period.</p><p>Revenue fell to 668.6 million yuan from 849.4 million yuan.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1141","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2562713133","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2562713133","pubTimestamp":1756282546,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Joinn Laboratories  posted a profit attributable to equity shareholders of 60.9 million yuan for the first half of 2025, reversing a loss of 169.7 million yuan a year earlier, according to a Tuesday Hong Kong bourse filing.Hong Kong-listed shares of the pharma research company fell nearly 5% in afternoon trade on Wednesday.Earnings per share came in at 0.08 yuan, compared with a loss per share of 0.23 yuan in the prior-year period.Revenue fell to 668.6 million yuan from 849.4 million yuan.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"603127":"昭衍新药","BK1141":"生命科学工具和服务","06127":"昭衍新药","BK1576":"医药外包概念","BK0216":"研究试验"},"translate_title":"Joinn Laboratories上半年恢复盈利；股价下跌5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603127":0.9,"06127":1},"content_text":"Joinn Laboratories (HKG:6127, SHA:603127) posted a profit attributable to equity shareholders of 60.9 million yuan for the first half of 2025, reversing a loss of 169.7 million yuan a year earlier, according to a Tuesday Hong Kong bourse filing.Hong Kong-listed shares of the pharma research company fell nearly 5% in afternoon trade on Wednesday.Earnings per share came in at 0.08 yuan, compared with a loss per share of 0.23 yuan in the prior-year period.Revenue fell to 668.6 million yuan from 849.4 million yuan.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}